Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Bulis Veronica Sanchez. Insider active across 1 company, notably Lyell Immunopharma, Inc.. In total, 5 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €52k. History available since 10 November 2025. The latest transaction was filed on 10 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bulis Veronica Sanchez is a declarant linked to Lyell Immunopharma, Inc. (XNAS), where the stated role is VP, Corporate Controller. The 4 filings on record are all tied to sales in the most recent filings we hold, between 2025-11-12 and 2026-06-15, with sell volume of EUR 44059; the top filings show EUR 37242.22732327323, EUR 3483.435937054798, and EUR 3333.281843740213.